Pentoxifylline Tablet, Extended Release
Product Images NDC 16571-856

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentoxifylline (NDC 16571-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pentoxifyllinelabel (Pentoxifyllinelabel)

Pentoxifyllinelabel (Pentoxifyllinelabel)
Label for Pentoxifylline Extended-Release Tablets, USP 400 mg by Rising Pharma Holdings, Inc. The package contains 500 tablets. The label includes dosage information, storage instructions to keep at controlled room temperature and protect from light, manufacturing details, and a barcode. The product is a human prescription drug in oral extended-release tablet form.*
FDA Label Image

Pentoxifyllinestruct (Pentoxifyllinestruct)

Pentoxifyllinestruct (Pentoxifyllinestruct)
Chemical structure of pentoxifylline showing its molecular framework with carbon, nitrogen, oxygen atoms, and attached methyl and acetyl groups.*
FDA Label Image

Pentoxifyllinetable (Pentoxifyllinetable)

Pentoxifyllinetable (Pentoxifyllinetable)
Table presenting the incidence of side effects in patients at risk using Pentoxifylline extended-release tablets versus placebo commercially, and immediate-release capsules in controlled clinical trials. Side effects are categorized by system (cardiovascular, digestive, nervous) with corresponding percentages for both Pentoxifylline and placebo groups, including patient counts and discontinuations for side effects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.